AGA Clinical Trials in Calgary, Alberta
4 recruitingCalgary, Alberta, Canada
Showing 1–4 of 4 trials
Recruiting
Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pancreatic Neuroendocrine TumorVon Hippel-Lindau DiseasePheochromocytoma/Paraganglioma+2 more
Merck Sharp & Dohme LLC322 enrolled84 locationsNCT04924075
Recruiting
Not Applicable
Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates
Vasovagal Syncope
University of Calgary25 enrolled1 locationNCT03446326
Recruiting
Phase 3
Study of Atomoxetine in the Prevention of Vasovagal Syncope
Vasovagal Syncope
University of Calgary180 enrolled1 locationNCT05159687
Recruiting
Phase 2
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
SyncopeVasovagal Syncope (VVS)
University of Calgary70 enrolled1 locationNCT05755737